This isn’t theoretical. Primary PFAS producers are already paying billions in PFAS-related settlements, and those numbers are just the beginning. But beyond headline lawsuits, many secondary PFAS users face significant risks, including environmental cleanup costs and quieter financial threats that are often overlooked:
- Costly product reformulations
- Export bans or customs delays
- Breach of supplier contracts
- Brand damage or lost retailer partnerships
- Insurability concerns
As reported in The New York Times, even downstream users, those who didn’t make or knowingly apply PFAS, are increasingly drawn into legal actions. The cost of being “unaware” is no longer a defense.
Manufacturers should be modeling a wide range of potential costs when assessing PFAS risk. These include testing and lab analysis, legal fees and potential judgments, reformulation expenses, retooling of production lines, business interruption from non-compliance or regulatory delays, and brand or reputational damage mitigation.
In some sectors, the financial impact is already being felt. For example, in the cosmetics industry, several brands delayed European product launches between 2023 and 2024 due to the need to reformulate “long-wear” products that previously relied on fluorinated compounds.
Insurers are also responding. PFAS exclusions are becoming more common, and some policies now require PFAS-free certifications or risk assessments as a condition for renewal. This shift is making it harder for companies to secure or maintain coverage, especially if they cannot demonstrate proactive risk management.